TrialBMC nephrology2026

Efficacy and safety of single high-dose intravenous ferric carboxymaltose in patients undergoing hemodialysis: a multicenter, single-arm, open-label, clinical trial.

Kosuke Osawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.